TKT and chronic myelogenous leukemia, BCR-ABL1 positive: Design, Synthesis, and Biological Evaluation of &lt;i&gt;N&lt;/i&gt;,&lt;i&gt;N&lt;/i&gt;-Diphenylaniline-Based Derivatives as Antiproliferative Agents and ABL TK Inhibitors Against CML.